公开(公告)号：US20240285666A1

公开(公告)日：2024-08-29

申请号：US18651293

申请日：2024-04-30

申请人： Bonafide Health, LLC

发明人： James R. Komorowski ,  Sarah Sylla ,  Devon Bernsley

IPC分类号： A61K31/7076 ,  A61K31/235 ,  A61K36/185 ,  A61K36/31 ,  A61K36/42 ,  A61K36/54 ,  A61K38/16 ,  A61P13/06

CPC分类号： A61K31/7076 ,  A61K31/235 ,  A61K36/185 ,  A61K36/31 ,  A61K36/42 ,  A61K36/54 ,  A61K38/168 ,  A61P13/06

摘要： Disclosed herein are compositions for supporting bladder health and/or treating, ameliorating, preventing, or reducing overactive bladder or the symptoms associated therewith. The compositions disclosed herein comprise a beta-adrenergic receptor agonist and at least one muscarinic receptor antagonist. Also described herein are methods utilizing the aforementioned compositions.

公开(公告)号：US20240108048A1

公开(公告)日：2024-04-04

申请号：US17958310

申请日：2022-09-30

申请人： Bonafide Health, LLC

发明人： James R. Komorowski ,  Sarah Sylla ,  Devon Bernsley

IPC分类号： A23L33/135 ,  A61K9/00 ,  A61K35/747 ,  A61K38/40 ,  A61K47/55 ,  A61P15/02

CPC分类号： A23L33/135 ,  A61K9/0053 ,  A61K35/747 ,  A61K38/40 ,  A61K47/551 ,  A61P15/02

摘要： Disclosed herein are oral formulations for treating, preventing, or ameliorating symptoms associated with bacterial vaginosis or yeast infections. The oral formulations disclosed herein comprise a probiotic composition and a supplement composition formulated as a single, multi-component formulation. Also described herein are methods utilizing the aforementioned oral formulations.

公开(公告)号：US12048712B2

公开(公告)日：2024-07-30

申请号：US18381558

申请日：2023-10-18

申请人： Bonafide Health, LLC

发明人： James R. Komorowski ,  Sarah Sylla ,  Devon Bernsley

IPC分类号： A61K36/00 ,  A61K31/235 ,  A61K31/7076 ,  A61K36/185 ,  A61K36/31 ,  A61K36/42 ,  A61K36/54 ,  A61K38/16 ,  A61P13/06

CPC分类号： A61K31/7076 ,  A61K31/235 ,  A61K36/185 ,  A61K36/31 ,  A61K36/42 ,  A61K36/54 ,  A61K38/168 ,  A61P13/06

摘要： Disclosed herein are compositions for supporting bladder health and/or treating, ameliorating, preventing, or reducing overactive bladder or the symptoms associated therewith. The compositions disclosed herein comprise a beta-adrenergic receptor agonist and at least one muscarinic receptor antagonist. Also described herein are methods utilizing the aforementioned compositions.

公开(公告)号：US20240122958A1

公开(公告)日：2024-04-18

申请号：US18381558

申请日：2023-10-18

申请人： Bonafide Health, LLC

发明人： James R. Komorowski ,  Sarah Sylla ,  Devon Bernsley

IPC分类号： A61K31/7076 ,  A61K31/235 ,  A61K36/185 ,  A61K36/31 ,  A61K36/42 ,  A61K36/54 ,  A61K38/16 ,  A61P13/06

CPC分类号： A61K31/7076 ,  A61K31/235 ,  A61K36/185 ,  A61K36/31 ,  A61K36/42 ,  A61K36/54 ,  A61K38/168 ,  A61P13/06

摘要： Disclosed herein are compositions for supporting bladder health and/or treating, ameliorating, preventing, or reducing overactive bladder or the symptoms associated therewith. The compositions disclosed herein comprise a beta-adrenergic receptor agonist and at least one muscarinic receptor antagonist. Also described herein are methods utilizing the aforementioned compositions.